Search
for
Sort by
Research 30 of 1000+
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Clascoterone: First Approval
- Class III Peroxidases PRX01, PRX44, and PRX73 Control Root Hair Growth in Arabidopsis thaliana
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Inhibition of class I HDACs preserves hair follicle inductivity in postnatal dermal cells
- Class III peroxidases PRX01, PRX44, and PRX73 potentially target extensins during root hair growth in Arabidopsis thaliana
- Clascoterone as a novel treatment for androgenetic alopecia
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Clascoterone in the Treatment of Acne Vulgaris: A Narrative Review
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- Clascoterone Cream 1% in Acne Management: Case Series and Real-World Canadian Experience
- Clascoterone: a new topical antiandrogen agent.
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- LO-009 Responsiveness of the CLASI to alopecia and mucous membrane involvement: a retrospective study of prospectively collected data
- Hair restoration; clinical study to evaluate the efficacy of a combined treatment between specific meso hair cocktail class III device and microneedling device in different baldness patterns
- Sequence-structure based phylogeny of GPCR Class A Rhodopsin receptors
- Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata
- MHC Class I-Like MILL Molecules Are β2-Microglobulin-Associated, GPI-Anchored Glycoproteins That Do Not Require TAP for Cell Surface Expression
- Study of Human Leukocyte Antigen ( HLA ) in 13 cases of familial frontal fibrosing alopecia: CYP 21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA ‐ A*33:01 ; B*14:02; C*08:02 as a genetic marker
- Multi-Class Support Vector Machine Classification for Detecting Alopecia Areata and Scalp Diseases
- MSF-VMDNet for multi class segmentation of skin cancer whole slide images using a multi frequency dual encoder network
- Distinguishing Three Classes of Androgenetic Alopecia based on Concerns in Youth: Latent Class Analysis of a Cross-Sectional Survey